| Improving children’s health and development in British Columbia through nurse home visiting: a randomized controlled trial protocol NLA Catherine, A Gonzalez, M Boyle, D Sheehan, SM Jack, KA Hougham, ... BMC health services research 16, 1-13, 2016 | 46 | 2016 |
| Knowledge, experiences and attitudes concerning genetics among retinoblastoma survivors and parents JA Hill, A Gedleh, S Lee, KA Hougham, H Dimaras European Journal of Human Genetics 26 (4), 505-517, 2018 | 37 | 2018 |
| Patient knowledge, experiences and preferences regarding retinoblastoma and research: a qualitative study C Moses, K Flegg, H Dimaras Health Expectations 23 (3), 632-643, 2020 | 13 | 2020 |
| The top 10 retinoblastoma research priorities in Canada as determined by patients, clinicians and researchers: a patient-oriented priority-setting partnership K Flegg, MJ Gelkopf, SA Johnson, H Dimaras Canadian Medical Association Open Access Journal 8 (2), E420-E428, 2020 | 11 | 2020 |
| The Canadian retinoblastoma research advisory board: a framework for patient engagement MJ Gelkopf, I Avramov, R Baddeliyanage, I Ristevski, SA Johnson, ... Research Involvement and Engagement 6, 1-21, 2020 | 9 | 2020 |
| Clinical audit of retinoblastoma management: a retrospective single-institution study A Selvarajah, K Flegg, W Sim, JB Hu, BL Gallie, F Shaikh, SE Soliman, ... Canadian Journal of Ophthalmology 57 (4), 257-269, 2022 | 7 | 2022 |
| Evidence that the association between exercise intensity and insulin sensitivity is sex dependent KA Hougham, R Ross Applied Physiology, Nutrition, and Metabolism 36 (5), 730-735, 2011 | 5 | 2011 |
| EMPOWER Retinoblastoma: Engaging Patient Partners in Solving the Top 10 Priorities for Eye Cancer Research in Canada I Ristevski, J Robert, R Baddeliyanage, R Noronha, M Gelkopf, K Flegg, ... Healthcare Quarterly 24, 11-17, 2022 | 2 | 2022 |
| The retinoblastoma research booklet: a catalyst for patient involvement in retinoblastoma research I Ristevski, J Kiew, M Hendry, M Prunier, R Noronha, M Al-Hammadi, ... Healthc Q 24, 61-68, 2022 | 2 | 2022 |
| DEPICT HEALTH supports clinical trial of sustained-release episcleral topotecan for retinoblastoma BL Gallie, S Soliman, F Shaikh, R Carvalho, T Truong, K Flegg, ... Investigative Ophthalmology & Visual Science 60 (9), 2322-2322, 2019 | 2 | 2019 |
| Characterization of international partnerships in global retinoblastoma care and research: A network analysis H Girdler, K Flegg, J Prochaska, H Dimaras PLOS Global Public Health 1 (12), e0000125, 2021 | 1 | 2021 |
| Co-creation of a pathway of care for retinoblastoma patients and families I Ristevski, K Flegg, M Livingstone, H Dimaras PEDIATRIC BLOOD & CANCER 67, S362-S363, 2020 | 1 | 2020 |
| Mapping global prevalence, treatment capacity, and expertise for retinoblastoma H Dimaras, K Hougham, J Fujioka Journal of Global Oncology, 25s-25s, 2018 | 1 | 2018 |
| THE RETINOBLASTOMA JOURNEY MAP: A PATIENT-CENTRED PATHWAY OF CARE I Ristevski, K Flegg, T Dorna, A Ulster, K Paton, S Kletke, A Mallipatna, ... PEDIATRIC BLOOD & CANCER 70, 2023 | | 2023 |
| ENROLLMENT AND PATIENT PREFERENCES IN PARTICIPATION IN A RARE PEDIATRIC EYE CANCER BIOBANK R Noronha, K Flegg, A Mallipatna, H Dimaras PEDIATRIC BLOOD & CANCER 70, 2023 | | 2023 |
| SUSTAINED-RELEASE TOPOTECAN EPISCLERAL CHEMOPLAQUE FOR RETINOBLASTOMA B Gallie, A Ramasubramanian, F Shaikh, A Mallipatna, S Kletke, ... PEDIATRIC BLOOD & CANCER 70, S106-S107, 2023 | | 2023 |
| DEVELOPING A BUSINESS PLAN FOR A RARE PEDIATRIC EYE CANCER BIOBANK K Flegg, R Noronha, H Dimaras, A Mallipatna PEDIATRIC BLOOD & CANCER 70, 2023 | | 2023 |
| BARRIERS AND FACILITATORS TO IMPLEMENTING RED REFLEX TEST GUIDELINES FOR RETINOBLASTOMA DIAGNOSIS AS DETERMINED BY PATIENTS, HEALTHCARE PROVIDERS AND RESEARCHERS B Lim, K Flegg, A Janic, J Craig, A Mallipatna PEDIATRIC BLOOD & CANCER 70, 2023 | | 2023 |
| Development of a Biobank for Rare Pediatric Eye Cancers H Dimaras, K Flegg, R Noronha | | 2023 |
| Development of a Pediatric Ophthalmology Biobank R Noronha, K Flegg, H Dimaras Investigative Ophthalmology & Visual Science 62 (8), 2850-2850, 2021 | | 2021 |
